A partial hold was placed on the trial after results showed variance between squamous and non-squamous NSCLC patient ...
Gorji joined DLA Piper, one of the biggest law firms in the world, as a litigation partner, adding to its FDA team, which ...
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...
Amneal Pharmaceuticals said the U.S. Food and Drug Administration has approved its new drug application for its medication pyridostigmine bromide extended-release tablets. The pharmaceutical company ...
The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...
The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...
The recall of the Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, was initiated on October 10 ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that the U.S. Food and Drug ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
With Diwali around the corner, the Food and Drug Administration (FDA) is increasing its vigilance and will be conducting a ...
Pitts, a former FDA associate commissioner, is president of the Center for Medicine in the Public Interest and a visiting ...